Medtronic Buy Rating Affirmed: Sustained Growth and Strong Pipeline Drive Positive Outlook
Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...
Medtronic PLC stock outperforms competitors despite losses on the day
Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.
MassDevice1d
Medtronic has a new VP, GM for TAVR, Congenital Heart
Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.
Zacks.com on MSN2d
Medtronic (MDT) Up 0.7% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for Medtronic (MDT). Shares have added about 0.7% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...
Medtronic: An Undervalued Stock With Durable Competitive Advantages
Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...
Medtronic PLC stock rises Thursday, still underperforms market
Shares of Medtronic PLC MDT advanced 1.52% to $89.47 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 ...
Yahoo Finance13d
How Much Would It Take To Earn $100 A Month From Medtronic Stock?
Medtronic plc (NYSE:MDT ... Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, ...
Seeking Alpha27d
Medtronic: Is The Company Back?
Medtronic sells products in many end markets in these segments ... The firm faced an FDA warning letter for Its MiniMed 600 insulin pump, which I highlighted in an earlier article.
Medtronic scores FDA approvals for several new therapies to drive sales
In April, Medtronic obtained FDA approval for another new product, Inceptiv, a spinal cord stimulator for treating chronic pain. The device can automatically adjust the therapy — a unique feature — to ...